InspireMD's CGuard™ Embolic Prevention Stent System to be Featured in Clinical Presentations and a Live Case Transmission at LINC 2022
globenewswire.com
business
2022-06-02 12:00:00

TEL AVIV, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke, today announced that the company will participate in the Leipzig Interventional Course (LINC) 2022, which is being held June 6-9 in Leipzig, Germany. The company will occupy Booth #36 during the conference. 'We are very pleased to again have a significant presence at this year's LINC conference, including an opportunity to showcase the CGuard™ EPS stent system in a live case procedure that is designed to demonstrate its clinical utility, design superiority with sustainable protection, resulting in superior patient outcomes and safety,' said Marvin Slosman, chief executive officer of InspireMD.
